1. Introduction {#sec1}
===============

The shifting attitude in biology from classical molecular biology to the systems biology has led to dramatic and profound changes in the study of living organisms. With the completion of multiple genome sequencing projects in recent decades, our insight into the understanding of genotype-phenotype relationships has been increasingly developed ([@bib19]; [@bib22]). The availability of whole genome sequences has enabled scientists to simulate appropriate models of metabolic networks so they can predict and manage the behavior of microorganisms with higher efficiency ([@bib8]; [@bib12]). Genome-scale metabolic network reconstructions are biochemical, genetic, and genomic (BiGG) structured knowledge bases that can be represented mathematically. Mathematical modeling of reconstructions can help scientists to find the right and effective targets of metabolic engineering ([@bib7]; [@bib9]; [@bib10]; [@bib30]; [@bib31]).

Genome-scale metabolic network reconstruction is a very laborious and time-consuming work, which in some cases requires teamworking of experts from several months to a few years ([@bib3]; [@bib5]). Genome-scale metabolic models are available for more than 100 organisms ([@bib35]). Likewise, for almost all of these organisms, there are multiple versions of metabolic network reconstructions. For example, one strain of cyanobacteria, the *Synechocystis* sp. PCC6803 has eleven different reconstructed metabolic networks developed by various research groups ([@bib7]; [@bib14]; [@bib16]; [@bib24]; [@bib29]; [@bib34]). Unfortunately, the published metabolic networks have been presented inconsistently with substantially different levels of annotations ([@bib32]). Also, all of the metabolic network reconstructions have varying degrees of completeness ([@bib25]). In a recent study, Ravikrishnan and Raman critically examined about 100 different metabolic networks ([@bib27]). Their study shows a significant inconsistency in published metabolic networks that makes it very difficult to compare and use them. The substantial lack of consistency and compatibility between metabolic networks highlights the urgent need for the development of an appropriate tool that can compare and merge them. Such a tool should produce enhanced metabolic network reconstructions without the need for more experimental tests and without detracting from the potential values of primary networks.

In this study, we developed a standalone, easy-to-use, graphical user interface (GUI) software tool **iMet** that can be used to integrate metabolic networks effectively. The iMet has been extensively tested on most common operating systems including Linux, Windows, and Macintosh. It is not web based and no other auxiliary software needed to run it. Using this tool, metabolic networks can be loaded, edited and integrated. Finally, the integrated network is given out in the standard SBML (Systems Biology Markup Language ([@bib13])) file format and will be ready for more analysis. It should be mentioned that we developed the initial version of this software in 2016 ([@bib23]), but in the current version, we added many other features and capabilities.

2. Materials and method {#sec2}
=======================

2.1. Algorithm {#sec2.1}
--------------

[Fig. 1](#fig1){ref-type="fig"} shows a schematic workflow of the algorithm. We can summarize the iMet software algorithm in the seven main steps below:Step 1. Validation of inputs and information extractionFig. 1Schematic workflow of the iMet algorithm.Fig. 1

In the first step, the validity of the input metabolic networks is evaluated for the SBML file format. Then, the details of the information about metabolic networks are extracted and displayed in an easily editable format. The main information extracted about genes, metabolites, and reactions include the following: Gene ID, E.C. (Enzyme Commission) Number ([@bib2]), KEGG ID ([@bib15]), UniProt ID ([@bib33]), CAS (Chemical Abstracts Service) Number, Formula, and ChEBI (Chemical Entities of Biological Interest) ID ([@bib4]).Step 2. Curating and enhancing of input models

After parsing the input metabolic networks, the users can edit inconsistent information about each metabolite and/or reaction. In addition, iMet uses KEGG database that has rich information about genes, metabolites, and reactions to enhance the quality of input networks by adding more information. This step can considerably enhance the process of networks integration. However, users can ignore this step and go straight to the next step if they want to.Step 3. Detection of similar metabolites

In this step, a similarity score is assigned to each pair of metabolites across two input metabolic networks. The main contributors to the similarity score of metabolites are similarities based on Name, KEGG ID, Protein ID, ChEBI ID, CAS Number, and Compartment.Step 4. Editing the similarities of metabolites

After detecting similar metabolites, there is a capability to revise the assigned similarity scores by the user in a simple manner.Step 5. Detection of similar reactions

In this step, similarity scores for each pair of reactions across two networks are computed. This score is computed according to the similarities of different features of reactions, including reactants, products, and the total number of them, stoichiometry coefficients of similar metabolites, and reversibility.Step 6. Editing the similarities of reactions

At this point, users can either accept or reject the reactions that are considered as similar or identical, in a similar way as step 4.Step 7. Integrating the input models

Finally, iMet integrates input metabolic networks using the detected similar or identical reactions as bridges. The obtained integrated metabolic network can be saved as a standard SBML file format for more analysis.

2.2. Implementation {#sec2.2}
-------------------

iMet is a standalone software tool to reconcile metabolic networks where metabolic networks can be loaded, edited and integrated. This tool has been implemented using the Java programming language as a cross-platform tool with a user-friendly graphical interface. [Fig. 2](#fig2){ref-type="fig"} shows the main parts of the graphical user interface of the iMet. This tool can be used on each operating system with a Java runtime environment (JRE). iMet has been extensively tested on the most common operating systems including Linux, Windows, and Macintosh.Fig. 2The main parts of the graphical user interface of the iMet. A)Start page of the iMet; B)Validation of inputs and information extraction; C) curating the input models; D)Collecting information from KEGG; E) Similar metabolites detection; F) Editing the similarities of metabolites; G)Detection of similar reactions; H)Integrating the input models.Fig. 2

iMet accompanied with sample files is available in the [supplementary file 1](#appsec1){ref-type="sec"} at the following web address: "<https://github.com/rmohamadi/iMet-Samples>". In addition, the source code of the iMet is available in the [supplementary file 2](#appsec1){ref-type="sec"} in the zip file format at this web address: "<https://github.com/rmohamadi/iMet_Source-Code>".

2.3. Main features {#sec2.3}
------------------

iMet is an efficient standalone software tool with a user-friendly GUI to integrate genome-scale metabolic network reconstructions. This tool has some distinguishing features that have summarized in [Table 1](#tbl1){ref-type="table"}.Table 1Distinguished features of the iMet software tool.Table 1FeaturesA brief descriptionCross-platform**iMet** can be run on the most common operating systems including Linux, Windows, and Macintosh.Graphical user interface**iMet** provides a user-friendly GUI (graphical user interface) that can be used easily by biologists with no significant computer science knowledge.SBML high compatibilityCurrently, SBML files are defined in three levels and each level has multiple versions. **iMet** supports all SBML file formats, which enables users to integrate metabolic networks that published by various research groups around the world at different times.Employing the supervision of expert usersBefore constructing the final integrated network, users can edit the input models (that displayed in an appropriate format) in a mouse-driven fashion. In addition, users can supervise the **iMet** by accepting or rejecting the detected similar metabolites or reactions and revising the similarity scores.Collecting information from online resources**iMet** can collect information about reactions and metabolites, such as KEGG IDs; ChEBI IDs; CAS Numbers and Metabolites\' alternative names, from the KEGG database. The obtained information can greatly influence the process of detecting similar metabolites and reactions and so can enhance the correctness of the integration steps.

3. Results {#sec3}
==========

3.1. Case study {#sec3.1}
---------------

Use of fossil fuels in the past decades has led to the accumulation of contaminants in natural ecosystems ([@bib1]; [@bib21]). Cyanobacteria are photosynthetic microorganisms that can take atmospheric Carbon dioxide (CO2) and produce organic compounds like third generation biofuels ([@bib6]; [@bib36]). In addition, they can produce oxygen during photosynthesis ([@bib26]). Hence, this group of microorganisms can be a good model to produce biofuels and reduce the pollution of ecosystems ([@bib18]; [@bib20]; [@bib26]; [@bib28]).

As a case study, we tried to integrate several metabolic network reconstructions of a cyanobacterium, *Synechocystis* sp. PCC 6803, using iMet. In this study, we took three different metabolic network reconstructions of this microorganism in SBML file format from three different study sources: a. Knoop, H., et al. (2010) ([@bib17]), b. Knoop, H., et al. (2013) ([@bib16]), and c. Erdrich, P., et al. (2014) ([@bib7]). Then, by the help of iMet, we merged these reconstructions to create a new reconstruction named *iMCyn1*. The SBML files of these reconstructions (three primary models and the *iMCyn1*) can be found in the [supplementary file 3](#appsec1){ref-type="sec"} in the zipped format at "<https://github.com/rmohamadi/Models-Analyses-Instruction>". The *.mat* files of these reconstructions are also included in the [supplementary file 3](#appsec1){ref-type="sec"}.

After merging the networks and creating *iMCyn1*, we have tried to model all reconstructions (included *iMCyn1*) to produce five biofuels by adding some reactions to the networks. These reactions added to propanol, isobutanol, 3-methyl-1-butanol, and 2-methyl-1-butanol metabolic pathways to provide the possibility of producing them. The production pathway of ethanol was complete and there was no need to add any other reaction. We also added excretion reactions to all biofuels and imposed several constraints on models ([@bib16]). We then performed the Flux Balance Analysis (FBA) ([@bib37]; [@bib31]) to compare the new merged model, *iMCyn1*, with the previously reported models. The instructions of these three steps (integrating metabolic network reconstructions by iMet, making new models by adding reactions and constraints and running FBA in the MATLAB) are available at this web address: "<https://github.com/rmohamadi/Models-Analyses-Instruction>".

The results of analyses showed an enhancement in the coverage of reactions and metabolites as well as an increment in the yields of desired products in *iMCyn1*, in comparison with primary models. In addition, the number of blocked reactions decreased for the production of 2-methyl-1-butanol ([Table 2](#tbl2){ref-type="table"}). The results of analyses and the list of reactions for biomass and biofuels with their related flux values are included in the [supplementary file 3](#appsec1){ref-type="sec"}.Table 2Comparison of previously reported models with our new model (iMCyn1).Table 2ModelsN. of MetabolitesN. of ReactionsN. of Blocked Reactions[1](#tbl2fn1){ref-type="table-fn"}Ethanol Fluxes[2](#tbl2fn2){ref-type="table-fn"}Propanol Fluxes3-methyl-1-butanol Fluxes2-methyl-1-butanol FluxesIsobutanol Fluxes1- Knoop, H. et al. ([@bib17])274380550.2250.02.15E-2601.89E-292- Knoop, H. et al. ([@bib16])556759550.64650.4310.24390.25710.31573- Erdrich, P. et al. ([@bib7])518600ND[3](#tbl2fn3){ref-type="table-fn"}NDNDNDNDND4- *iMCyn1*557768520.66010.44000.25260.26400.5658[^1][^2][^3]

4. Discussion and conclusion {#sec4}
============================

According to [Table 2](#tbl2){ref-type="table"}, there are no complete and reliable FBA results for the third Model ([@bib7]) as it does not have any information about genes or gene IDs. Despite the fact that analyzing the third model was failed, merging it into model 2 and model 1 caused a significant improvement in FBA results of *iMCyn1* (Please refer to the results of analyses in the [supplementary file 3](#appsec1){ref-type="sec"}).

Furthermore, merging the incomplete model 1 ([@bib17]) into the others was useful too. An increment in the flux of some biofuels could be seen by merging model 1 into model "2 + 3" (i.e. merged of 2 and 3). For example, it can be seen that the result of FBA for isobutanol production has increased from 3.27E-01 mmol/gDW/h in model "2 + 3" to 5.66E-01 mmol/gDW/h in *iMCyn1*. These two outcomes have been highlighted in the analyses result section in the [supplementary file 3](#appsec1){ref-type="sec"}.

To date, few approaches that have not been completed yet, have been made on merging metabolic networks of organisms. This study is an endeavor to make a further step forward in this area, by using a progressive approach. The results of the case study show that the additional information which is added by iMet in the process of merging could improve the functionality of the output network without any reduction in the previous functionalities.

Furthermore, the iMet can detect different types of inconsistencies and correct them. These inconsistencies can be in identifiers, names, standard identifiers, stoichiometric coefficients, and reversibility of reactions. The design of the iMet algorithm, allows us to correct most of these inconsistencies. Another part of the inconsistencies, including the mass balance and the atoms, can be corrected by the user at each step of the merging. In general, by information enrichment of various databases and the greater the degree of monitoring in each phase of integration, the probability of such errors will be reduced.

The production of futile cycles or type II pathways during reconstruction and modeling of metabolic networks may occur most often by automated methods. These futile cycles can result in infeasible and implausible production fluxes of ATP, reducing equivalents, or other substrates ([@bib11]). However, since at each step of the iMet algorithm there is a manual monitoring and supervising phase, iMet can then be useful in removing and correcting such cycles or pathways.

The results of analyses in our case study showed the performance of this software. These results show the superior performance of the iMet which can be profitable in other studies related to different types of organisms. In spite of the fact that monitoring and manual revising of similarity scores could lead to a better result by iMet, it is also capable to operate in a fully automated mode, which is really useful while facing to a huge network.

iMet is a standalone easy to use software application with a user-friendly GUI, that enables the integration of the metabolic networks in a mouse-driven fashion. In other words, there is no need for web access or any other auxiliary software to use it. However, web access might cause a better result. iMet satisfies the urgent need for an in-silico tool to reconcile existing incomplete metabolic networks into an enhanced metabolic network without any experimental efforts. iMet is freely available for academic and non-commercial use at "<https://github.com/rmohamadi/iMet-Samples>".
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[^1]: In 2-methyl-1-botanol production pathway.
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[^3]: Not Defined.
